Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway

[1]  Kai Chen,et al.  Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study , 2014, European Journal of Drug Metabolism and Pharmacokinetics.

[2]  K. Bishayee,et al.  5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy. , 2013, Acta biochimica et biophysica Sinica.

[3]  V. Magrioti,et al.  Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present) , 2013, Expert opinion on therapeutic patents.

[4]  E. Dennis,et al.  Using Hydrogen/Deuterium Exchange Mass Spectrometry to Define the Specific Interactions of the Phospholipase A2 Superfamily with Lipid Substrates, Inhibitors, and Membranes* , 2012, The Journal of Biological Chemistry.

[5]  S. Im,et al.  Glutamine Suppresses Airway Neutrophilia by Blocking Cytosolic Phospholipase A2 via an Induction of MAPK Phosphatase-1 , 2012, The Journal of Immunology.

[6]  Liang-yuan Ouyang,et al.  [Effect of magnesium isoglycyrrhizinate on PLA2 during liver tissue injury following limb ischemia/reperfusion in rats]. , 2012, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[7]  B. Konkle.  Acquired disorders of platelet function. , 2011, Hematology. American Society of Hematology. Education Program.

[8]  K. Ramana,et al.  Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages. , 2011, Free radical biology & medicine.

[9]  C. Agostoni,et al.  Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2. , 2011, Clinical nutrition.

[10]  Wen-Hsieh Lo,et al.  Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions. , 2011, Journal of agricultural and food chemistry.

[11]  Y. Miki,et al.  Recent progress in phospholipase A₂ research: from cells to animals to humans. , 2011, Progress in lipid research.

[12]  A. Agarwal,et al.  Dual inhibitory effect of Glycyrrhiza glabra (GutGard™) on COX and LOX products. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  P. Barnes.  Mechanisms and resistance in glucocorticoid control of inflammation , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Jiyong Liu,et al.  [Effect of magnesium isoglycyrrhizinate on allergy contact dermatitis (ACD) in mice]. , 2010, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[15]  Qing Liu,et al.  Protective Effect of Magnesium Isoglycyrrhizinate on Ethanol-Induced Testicular Injuries in Mice , 2010, Journal of biomedical research.

[16]  Ying Sun,et al.  [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study]. , 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[17]  Yuan Cheng,et al.  Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity in HepG2 Cells by Magnesium Isoglycyrrhizinate in vitro , 2009, Pharmacology.

[18]  J. D. Clark,et al.  Benzhydrylquinazolinediones: novel cytosolic phospholipase A2alpha inhibitors with improved physicochemical properties. , 2009, Bioorganic & medicinal chemistry.

[19]  Min Ye,et al.  Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). , 2009, Journal of chromatography. A.

[20]  E. Dennis,et al.  Phospholipase A2 Biochemistry , 2009, Cardiovascular Drugs and Therapy.

[21]  R. Gross,et al.  Eicosanoid signalling pathways in the heart. , 2008, Cardiovascular research.

[22]  J. D. Clark,et al.  Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib. , 2008, Journal of medicinal chemistry.

[23]  Hossein Hosseinzadeh,et al.  Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds , 2008, Phytotherapy research : PTR.

[24]  J. D. Clark,et al.  Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacy. , 2008, Bioorganic & medicinal chemistry.

[25]  Lungen Lu,et al.  Phase I Safety and Pharmacokinetic Study of Magnesium Isoglycyrrhizinate After Single and Multiple Intravenous Doses in Chinese Healthy Volunteers , 2007, Journal of clinical pharmacology.

[26]  S. Khor,et al.  Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α , 2007 .

[27]  S. Abramson,et al.  Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. , 2006, Clinical immunology.

[28]  P. Barnes.  Corticosteroids: the drugs to beat. , 2006, European journal of pharmacology.

[29]  John C. McKew,et al.  Inhibition of Cytosolic Phospholipase A 2 a: Hit to Lead Optimization , 2006 .

[30]  Mushfiquddin Khan,et al.  Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide‐induced inducible nitric oxide synthase expression in glial cells , 2005, Glia.

[31]  R. Sokol,et al.  Licorice Compounds Glycyrrhizin and 18β-Glycyrrhetinic Acid Are Potent Modulators of Bile Acid-induced Cytotoxicity in Rat Hepatocytes* , 2005, Journal of Biological Chemistry.

[32]  F. Curreli,et al.  Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. , 2005, The Journal of clinical investigation.

[33]  J. Cohen.  Licking latency with licorice. , 2005, Journal of Clinical Investigation.

[34]  C. Fiore,et al.  On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. , 2004, Biochimica et biophysica acta.

[35]  D. Simmons,et al.  The cyclooxygenases , 2004, Genome Biology.

[36]  C. Fiore,et al.  Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. , 2003, Biochemical pharmacology.

[37]  C. Charlier,et al.  Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. , 2003, European journal of medicinal chemistry.

[38]  Tianhan Xue,et al.  Studying Traditional Chinese Medicine , 2003, Science.

[39]  J. J. Moreno,et al.  Calcium‐independent phospholipase A2 through arachidonic acid mobilization is involved in Caco‐2 cell growth , 2002, Journal of cellular physiology.

[40]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. J. Moreno,et al.  Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species. , 2001, Archives of biochemistry and biophysics.

[42]  G. Lin,et al.  The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. , 1999, Toxicon : official journal of the International Society on Toxinology.

[43]  Brouwer,et al.  glycyrrhizin as a potential treatment for chronic hepatitis C , 1998, Alimentary pharmacology & therapeutics.

[44]  S. Buch,et al.  Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. , 1997, The American journal of clinical nutrition.

[45]  T. Yokochi,et al.  Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. , 1993, Immunology.

[46]  R. Pollard,et al.  Inhibition of burn‐associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells , 1993, Immunology and cell biology.

[47]  J. D. Clark,et al.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP , 1991, Cell.

[48]  M. Murakami,et al.  Emerging roles of secreted phospholipase A(2) enzymes: an update. , 2013, Biochimie.

[49]  M. Otuki,et al.  Selective inhibition of cyclooxygenase-2: risks and benefits. , 2012, Revista brasileira de reumatologia.

[50]  K. Ramana,et al.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages. , 2012, Free radical biology & medicine.

[51]  Kei Yamamoto,et al.  Analysis of Two Major Intracellular Phospholipase A 2 s in Mast Cells Reveals Crucial Contribution of cPLA 2 α , not iPLA 2 β , to Lipid Mobilization in Proximal Mast Cells and Distal Fibroblasts , 2011 .

[52]  S. Khor,et al.  Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha. , 2007, Journal of medicinal chemistry.

[53]  G. Kuttan,et al.  Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[54]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[55]  R. D. de Man,et al.  Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. , 1998, Alimentary pharmacology & therapeutics.

[56]  P. Belinky,et al.  Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. , 1997, Free radical biology & medicine.